PDC Therapeutics
PrivateLast Round
Series A
Dec 15, 2021
Total Funding Raised
$14.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PDC Therapeutics is a biotechnology company that develops targeted Polymer-Drug Conjugate technologies for cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PDC Therapeutics Comparables
Compare PDC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cybrexa Therapeutics | 82% | |
| Beihai Biotech | 77% | |
| OncoNano Medicine | 74% | |
PDC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2021 |
PDC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACT Venture Partners | Seed |
| İstanbul Portföy Yönetimi | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 374% MoM, from 358 to 1.7K.
- May 1, 2025
Monthly visitors increased 156% MoM.
PDC Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PDC Therapeutics's valuation, stock price, and market status.